Anne Robinson

5.5k citations

107 papers · 2.6k indexed · h-index 30

Impact in

Genetics top 0.5%
- Inflammatory Bowel Disease
Epidemiology top 1%
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders

Papers in

Genetics 86
- Inflammatory Bowel Disease 85
Epidemiology 76
- Microscopic Colitis 71
- Autoimmune and Inflammatory Disorders 13

Co-authors: William J. Sandborn Roopal Thakkar Remo Panaccione Paul F. Pollack Jean–Frédéric Colombel Walter Reinisch Jean‐Frédéric Colombel Geert D’Haens
Journals: Gastroenterology (24 papers)Inflammatory Bowel Diseases (19 papers)Journal of Crohn s and Colitis (14 papers)The American Journal of Gastroenterology (12 papers)Alimentary Pharmacology & Therapeutics (8 papers)
Partner nations: United States Canada Germany

In The Last Decade

Anne Robinson

98 papers receiving 2.6k citations

Peers

Countries citing papers authored by Anne Robinson

Since Specialization

Citations

This map shows the geographic impact of Anne Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Robinson more than expected).

Fields of papers citing papers by Anne Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Robinson. The network helps show where Anne Robinson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anne Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Robinson Line = papers co-authored together Anne Robinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation. Journal of Clinical Oncology* ·Salman R. Punekar, Meredith Pelster, Carlos Becerra, J. Randolph Hecht, Andrew Scott Paulson, Patrick Grierson, Maria Pia Morelli, Rom S. Leidner, Mandana Kamgar, Joaquina Baranda, Syed Mohammad Ali Kazmi, Ardaman Shergill, Anne Robinson, Anuradha Patel, A Hoffmann, Jeroen van Heijst, Nathan Demars, Arianne Perez, Sarah S. Cohen, Marwan Fakih	2024	3
2	AB-101, an allogeneic, non–genetically modified, natural killer (NK) cell therapy, evaluated as monotherapy or in combination with rituximab in R/R non-Hodgkin lymphoma. Journal of Clinical Oncology ·Rashmi Khanal, Amitkumar Mehta, Joseph Maly, Houston Holmes, Jennifer N. Saultz, Ayad Hamdan, Anne Robinson, Mili Mandal, Tenghua Wang, Thorsten Graef, Anita G. Seto, Umar Farooq	2023	3
3	Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn’s disease: results from a randomized trial Therapeutic Advances in Gastroenterology ·Baili Chen, Xiang Gao, Jie Zhong, Jianlin Ren, Xuan Zhu, Zhanju Liu, Kaichun Wu, Jasmina Kalabic, Adrio Toucer, Bidan Huang, Nisha V. Kwatra, Thao Doan, Anne Robinson, Minhu Chen	2020	27
4	The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn’s disease: a post hoc analysis Alimentary Pharmacology & Therapeutics ·Jeffrey S. Hyams, Marla C. Dubinsky, Joel R. Rosh, Frank M. Ruemmele, Samantha Eichner, Jen‐Fue Maa, Andreas Lazar, Gabriela Alperovich, Nael M. Mostafa, Anne Robinson	2018	21
5	Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis Alimentary Pharmacology & Therapeutics ·Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Laurent Peyrin‐Biroulet, Remo Panaccione, P. Rutgeerts, Stephen B. Hanauer, Subrata Ghosh, Gert Van Assche, Anne Robinson, Winnie Lau, S. Ramani, B Huang, Brandee Pappalardo, Holly A. Read	2017	32
6	Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis Journal of Gastroenterology ·Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Toshifumi Hibi∥, Shirô Nakamura, Andreas Lazar, Anne Robinson, Martha Skup, Nael M. Mostafa, Bidan Huang, Roopal Thakkar, Mamoru Watanabe	2017	8
7	Responsiveness of Endoscopic Indices of Disease Activity for Crohn’s Disease The American Journal of Gastroenterology ·Reena Khanna, Guangyong Zou, Larry Stitt, Brian G. Feagan, William J. Sandborn, Paul Rutgeerts, John WD McDonald, Elena Dubcenco, Ronald Fogel, Remo Panaccione, Vipul Jairath, Sigrid Nelson, Lisa M. Shackelton, Bidan Huang, Qian Zhou, Anne Robinson, Barrett G. Levesque, Geert D’Haens	2017	35
8	Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy Alimentary Pharmacology & Therapeutics ·J F Colombel, Bindia Jharap, William J. Sandborn, Brian G. Feagan, Laurent Peyrin‐Biroulet, Samantha Eichner, Anne Robinson, Nael M. Mostafa, Qian Zhou, Roopal Thakkar	2016	33
9	Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3 The American Journal of Gastroenterology ·Jean–Frédéric Colombel, William J. Sandborn, Subrata Ghosh, Douglas C. Wolf, Remo Panaccione, Brian G. Feagan, Walter Reinisch, Anne Robinson, Andreas Lazar, Martina Kron, Bidan Huang, Martha Skup, Roopal Thakkar	2014	124
10	Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis Journal of Gastroenterology ·Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Takayuki Matsumoto, Toshifumi Hibi∥, Anne Robinson, Nael M. Mostafa, Jingdong Chao, Vipin Arora, Anne Camez, Roopal Thakkar, Mamoru Watanabe	2013	133
11	Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease Gastroenterology ·Mark T. Osterman, William J. Sandborn, Jean–Frédéric Colombel, Anne Robinson, Winnie Lau, Bidan Huang, Paul F. Pollack, Roopal Thakkar, James D. Lewis	2013	129
12	Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn’s disease Current Medical Research and Opinion ·William J. Sandborn, J F Colombel, Geert D’Haens, Scott E. Plevy, Julián Panés, Anne Robinson, P Pollack, Qian Zhou, Ilsup Shin, Roopal Thakkar	2013	21
13	Exploring the use of adalimumab for patients with moderate Crohn's disease: Subanalyses from induction and maintenance trials Journal of Crohn s and Colitis ·William J. Sandborn, Jean‐Frédéric Colombel, Julián Panés, Ilsup Shin, Anne Robinson, Qian Zhou, Mei Yang, Roopal Thakkar	2013	11
14	Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease Journal of Crohn s and Colitis ·Stefanie Schreiber, Walter Reinisch, J F Colombel, William J. Sandborn, Daniël W. Hommes, Anne Robinson, B Huang, Kathleen G. Lomax, P Pollack	2012	136
15	Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease Inflammatory Bowel Diseases ·Jean‐Frédéric Colombel, Brian G. Feagan, William J. Sandborn, Gert Van Assche, Anne Robinson	2011	102
16	What is the short term effect of perfumes on olfactory thresholds? The Journal of Laryngology & Otology ·Anne Robinson, まゆ森, Carl Philpott, P Goodenough, منار عز الدين محمد شعيب, Allan Clark, G. E. Murty	2007	3
17	Investigation and management of adult periorbital and orbital cellulitis The Journal of Laryngology & Otology ·Anne Robinson, Ignacio J. Urricelqui Pacho, Ann-Louise McDermott, Anjana Sinha	2006	16
18	The specificity and affinity of immunoliposome targeting to oral bacteria Biochimica et Biophysica Acta (BBA) - Biomembranes ·Anne Robinson, Jonathan E. Creeth, Malcolm N. Jones	1998	39
19	Prognostic factors in juvenile chronic granulocytic leukaemia. PubMed ·Ксения Юрьевна Торговитская, Ian Lewis, Mary Morgan, Anne Robinson, 寛正新家	1992	6
20	Gastroesophageal fundoplication improves symptoms in refractory asthma. PubMed ·张作秀, Bart Chernow, Assemgul Uderbayeva, Jennifer A. Deal, Anne Robinson, Beth Barber, Ewelina Wesołek	1983	5

About Anne Robinson

Anne Robinson is a scholar working on Genetics, Epidemiology, Gastroenterology, Hematology and Rheumatology, having authored 107 papers that have together received 2.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (85 papers), Microscopic Colitis (71 papers), Eosinophilic Esophagitis (13 papers), Autoimmune and Inflammatory Disorders (13 papers), Immunodeficiency and Autoimmune Disorders (10 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Systemic Lupus Erythematosus Research (8 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). The work is most often cited by research in Genetics (2.1k citations), Epidemiology (1.8k citations), Gastroenterology (170 citations), Immunology (524 citations) and Hematology (207 citations). Anne Robinson has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include William J. Sandborn, Roopal Thakkar, Remo Panaccione, Paul F. Pollack, Jean–Frédéric Colombel, Walter Reinisch, Jean‐Frédéric Colombel, Geert D’Haens, Anne Camez and Jingdong Chao. Their work appears in journals such as Gastroenterology, Inflammatory Bowel Diseases, Journal of Crohn s and Colitis, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact